SAN DIEGO, Sept. 27, 2022 /PRNewswire/ — Kintara Therapeutics, Inc. (Nasdaq: KTRA) (“Kintara” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced financial results for its fiscal year ended June 30, 2022 and provided a corporate update. CORPORATE HIGHLIGHTS AND RECENT […]
Results
InMed Pharmaceuticals Reports Full Year Fiscal 2022 Financial Results and Provides Business Update
InMed Pharmaceuticals Inc. VANCOUVER, British Columbia, Sept. 23, 2022 (GLOBE NEWSWIRE) — InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today reported financial results for the fiscal year ended June 30, 2022. Conference Call […]
Relief Reports Half-Year 2022 Results and Provides Corporate Update
GENEVA, SWITZERLAND / ACCESSWIRE / September 15, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (“Relief”), a Swiss, commercial-stage biopharmaceutical company seeking to provide patients therapeutic benefit from selected specialty, rare and ultra-rare diseases with high unmet need, today reported its results for the half-year ended June 30, 2022 and provided […]
Eastman Provides Update on Third-Quarter 2022 Economic Results
KINGSPORT, Tenn., September 13, 2022–(Organization WIRE)–Eastman Chemical Firm (NYSE:EMN) provided an update on its 3rd-quarter 2022 monetary final results. Third-quarter 2022 altered earnings for each share (EPS) are predicted to be somewhere around $2.00. Prior expectations were being for good progress when compared to third-quarter 2021 altered EPS of $2.46. […]
Softrock Minerals announces shareholder conference final results in
Not for distribution to U.S. Newswire Services or for release, publication, distribution or dissemination, directly or indirectly, in total or in part, in or into the United States CALGARY, Alberta, Sept. 08, 2022 (Globe NEWSWIRE) — Softrock Minerals Ltd. (“Softrock” or the “Company”) (TSXV: SFT.V) is pleased to announce that […]
Centaurus Energy Inc. Announces 2022 Second Quarter Financial Results and Operational Update
(All dollar figures are expressed in United States Dollars) Buenos Aires, Argentina–(Newsfile Corp. – August 29, 2022) – Centaurus Energy Inc. (TSXV: CTA) (OTC Pink: CTARF) (“Centaurus” or the “Company”) is pleased to announce its financial and operating results for the six months ended June 30, 2022. Centaurus’ CEO David […]
Junshi Biosciences Announces 2022 Interim Financial Results and Provides Corporate Updates
Junshi Biosciences — Clinical trials of core drug candidates are progressing steadily with the debut of the company’s FIH asset — Toripalimab’s sales performance is consistently improving; the US BLA is under review SHANGHAI, China, Aug. 31, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; […]
Victory Square Technologies Reports 2022 Q2 Financial Results & Corporate Update
Victory Square Technologies Inc. 2022 Q2 unaudited Net Asset Value (“NAV”) of $89,704,469 as at June 30, 2022 Notable Portfolio Highlights: IV Hydreight, Creator.co, GameOn, XR Immersive, Next Decentrum, Stardust Solar, CoPilot, Fansunite, Turnium, Covalent CQT and CloudAdvisors Company & Executive Team featured in Forbes, Yahoo Finance, Entrepreneur, CoinTelegraph and […]
Antengene Announces Interim 2022 Financial Results and Provides Corporate Update
– Revenue of RMB 53.96 million mainly driven by the commercial launch of XPOVIO® (selinexor) in Mainland China on May 13, 2022 – Adjusted loss reduced to RMB 126 million for the first six months of 2022 from RMB 210 million in the same period last year – Cash and bank balances […]
Kinarus Therapeutics Reports H1 2022 Financial Results and Provides Corporate Update
Kinarus Therapeutic Holding AG Interim data from Phase 2 KINETIC clinical trial of KIN001 to treat hospitalized COVID-19 patients expected in Q3 2022 First patient dosed with in Phase 2 KINFAST clinical trial with ambulatory COVID-19 mild-patients Signed a CHF 20 million financing with Yorkville Advisors Fully financed until Q1 […]
Discovery Reports Q2 2022 Financial Results and Update
Discovery Silver Corp. TORONTO, Aug. 25, 2022 (GLOBE NEWSWIRE) — Discovery Silver Corp. (TSX-V: DSV, OTCQX: DSVSF) (“Discovery” or the “Company”) is pleased to announce its financial results for the three months ended June 30, 2022 (“Q2 2022”) and provide a summary of key events for the quarter, and subsequent […]
Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2022 Financial Results
Quoin Pharmaceuticals, Inc. Initiates clinical trial evaluating lead product candidate, QRX003 for Netherton SyndromeExpands number of commercial partnerships to eight, covering 60 countriesSigns Research Agreement to develop a product for the treatment of scleroderma Closes $16.8 million public offering, with net proceeds of approximately $15.0 million ASHBURN, Va., Aug. 18, […]
Inpixon Reports Second Quarter 2022 Financial Results and Provides Business Update
Achieves 55% Increase in Revenue for Six Months Ended June 30, 2022 Versus Same Period Last Year Conference Call to be Held Today at 4:30 p.m. Eastern Time PALO ALTO, Calif., Aug. 15, 2022 /PRNewswire/ — Inpixon® (Nasdaq: INPX), the Indoor Intelligence® company, today provided a business update and reported financial […]